However, Eli Lilly launched its own weight loss pill, orforglipron, marketed as Foundayo, in April. And the company has ...
Oral GLP-1 drugs have been around for a few years, but formulations specifically for weight loss are new, and a new pill is ...
Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, have set high ...
MedPage Today on MSN
GLP-1 drug makes its case for treating plaque psoriasis
Adding tirzepatide helped patients shed pounds, improved complete skin clearance rates ...
Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation, ...
Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with T2DM by evaluating underlying mechanisms, treatment efficacy, medication safety profiles, and ...
How Gala GLP-1 Compounded Semaglutide, Tirzepatide, and Microdosing Options Work for Prescription Weight Management Without ...
Viking Therapeutics Inc. said after-market hours Feb. 11 that it plans to advance its oral dual GLP-1/GIP receptor, VK-2735, into a phase III trial for obesity in the third quarter of 2026. VK-2735 is ...
New research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that ...
SureNano Science is developing GEP-44 as a patented next-generation metabolic therapy designed to address the limitations of first-generation GLP-1 drugs . The commercial potential tied to GLP-1 ...
Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results